CB vs ZURVY: Which Is the Better Buy in 2026?

Last updated November 2026

Short answer

CB is the larger of the two ($144.28B market cap): the incumbent the market prices for continued execution (12.81x forward earnings, beta 0.29). ZURVY is the smaller challenger ($112.62B), priced similarly on forward earnings (14.50x): more room to run, but more to prove. ZURVY is expected to grow revenue faster (10% vs 4% next year) at a similar price (14.5x vs 12.81x forward earnings). The case for CB rests on its own driver (Underwriting discipline and margins): if you believe in that, CB fits; if you believe in what the numbers show today, ZURVY does.

CB vs ZURVY: the tie-breaker metrics

Same yardstick, side by side (as of November 2026). Valuation lined up like this is most meaningful for two names in the same corner of the market, which these are. Figures are approximate; verify before investing.

MetricCBZURVYWhat it tells you
Market cap$144.28B$112.62BSize. The larger name is the incumbent; the smaller has more room to grow and more to prove.
Forward P/E12.8114.50Valuation on next year's expected earnings, the same yardstick for both. Lower is cheaper for that growth; higher means the market is paying up.
Trailing P/E13.2415.26Valuation on the last 12 months. A big drop from trailing to forward means the market expects earnings to jump, so more growth is already in the price.
Beta0.290.27Volatility vs the market. Above 1 swings harder than the index; below 1 is steadier. Higher beta means bigger drawdowns to hold through.
Price vs 52-week range93% of range68% of rangeWhere today's price sits between the 52-week low and high. Near the high is momentum with less margin of safety; near the low is out of favor or a discount, depending on why.
Price / book1.973.54How much you pay over book value. Very high can signal an asset-light, high-return business or a rich price.

Before you buy: how CB and ZURVY affect your concentration

The metrics above tell you which is the marginally better business. The bigger risk for most people is not picking the slightly worse stock, it is over-concentrating. CB and ZURVY share themes, so owning both, or adding either to what you already hold, can quietly push a large share of your portfolio into one bet.

This is the part a generic comparison page cannot answer, because it depends on what you own. Connect your brokerage and Walnut shows your real, combined CB and ZURVY exposure, flags overlap with your existing positions, and tells you if adding one would tip you past a concentration you are comfortable with, read-only by default, with your login staying at your broker. Walnut is not an investment adviser.

What does Chubb Limited (CB) do?

Chubb Limited is a global insurance company headquartered in Zurich, Switzerland, and one of the largest publicly traded property and casualty (P&C) insurers in the world. It underwrites commercial and personal P&C insurance, accident and health coverage, reinsurance, and life insurance across roughly 54 countries, serving multinational corporations, businesses, and individuals. Its scale and worldwide network let it service large multinational accounts that smaller carriers cannot, which creates a competitive barrier. The company is widely regarded for underwriting discipline, meaning it prioritizes writing profitable policies over chasing premium volume.

Full CB guide

What does Zurich Insurance Group AG (ZURVY) do?

Zurich Insurance Group AG is one of Europe's largest insurers, founded in 1872 and based in Zurich, with about 60,000 employees. It reports three businesses. Property and casualty (P&C) is the biggest: commercial insurance for companies of every size, including the Global Specialty lines, plus retail motor and home cover. Life sells protection and savings products, mostly in Europe, Latin America and Asia Pacific. Farmers is the odd one out. Zurich owns Farmers Group, Inc., which runs the US Farmers Exchanges for a management fee; the exchanges belong to their policyholders, so Zurich earns fee income without carrying their underwriting risk.

Full ZURVY guide

CB vs ZURVY: how do they differ?

Both fit overlapping themes, but they are not interchangeable. Here is what each one depends on.

  • CB drivers: Underwriting discipline and margins; Rising investment income.
  • ZURVY drivers: Commercial and specialty insurance, now with Beazley; Retail P&C pricing.

Which fits which kind of investor

A faster-growing, richer-valued name usually swings harder, so it suits a longer horizon and a higher tolerance for volatility; a steadier, more cash-generative business suits a more conservative or income-minded investor. A useful test is which set of risks you could hold through a drawdown: As a P&C insurer, Chubb is exposed to large catastrophe losses from hurricanes, wildfires, earthquakes, and other severe events, which can compress margins in a bad year. For ZURVY, catastrophe losses are the most visible risk.

CB or ZURVY: which should you pick?

If the story you believe is CB's (Underwriting discipline and margins), CB is the more direct way to own it; if it is ZURVY's (Commercial and specialty insurance, now with Beazley), ZURVY is. Many investors hold both, but since they share themes, that is a concentrated bet, not diversification. Decide deliberately and check overlap. For the full detail, see the CB and ZURVY guides.

CB vs ZURVY: the full fundamentals

CB. As of November 20, 2026, Chubb trades near $378, about 13.2 times trailing earnings and about 2 times book value, broadly in line with large P&C peers even after a 22% gain this year. Third-quarter 2026 EPS of $7.66 beat consensus by about $0.86. The multiple leaves little premium for growth, which fits consensus EPS of about $29.47 in 2027, close to the 2026 figure.

ZURVY. Zurich reports in US dollars, pays its dividend in Swiss francs and trades in francs on SIX, so every ratio mixes currencies. At CHF 652 a share on 17 November (about US$777 at the rate implied by the ADR that day) and core earnings of about US$45 a share for 2025, the stock traded near 17 times trailing earnings and roughly 16 times an annualised first-half 2026 run rate of US$24.2; Yahoo Finance's figures for the ADR at US$37.70 on 20 November show about 15 times trailing and 14.5 times forward. Core return on equity was about 27% in 2025. The dividend yield is a gross Swiss figure, before the 35% withholding tax, and moves with the franc-dollar rate. The three analysts Yahoo Finance tracks on the ADR have a mean target near US$43.65 and a hold rating.

Headline figures (approximate, November 2026): CB shows revenue (ttm) ~$61.9 billion, revenue growth (q3 2026) roughly flat year over year (~$13.2 billion), q3 2026 eps $7.66 vs ~$6.80 est., net income (ttm) ~$11.2 billion (~18% profit margin); ZURVY shows adr price (20 nov 2026) ~US$37.70 (1 ADR = 1/20 share), home share price (six, 17 nov 2026) ~CHF 652, market value ~US$113 billion (Yahoo Finance), business operating profit (fy2025) ~US$8.9 billion.

The bottom line: CB vs ZURVY

CB and ZURVY are related but distinct: same themes, different businesses and risks. Neither wins in the abstract, and whichever you pick is worth sizing so one theme does not take over your portfolio. Walnut can show your combined CB and ZURVY exposure against your real portfolio. It is not an investment adviser.

Wondering how CB or ZURVY fits the portfolio you already own? Walnut is an AI investing app that connects your brokerage read-only and answers questions like that about your actual holdings: overlap, concentration, and how each position tracks the S&P 500. Compare the best AI portfolio analyzers or see the best AI investing apps in 2026.

Your questions about Chubb Limited

Ask Walnut's AI anything about CB and see how it fits what you own.

FAQ

What is the difference between CB and ZURVY?

+

Chubb Limited is a global insurance company headquartered in Zurich, Switzerland, and one of the largest publicly traded property and casualty (P&C) insurers in the world. Zurich Insurance Group AG is one of Europe's largest insurers, founded in 1872 and based in Zurich, with about 60,000 employees. They show up together because they share investment themes, but they are different businesses, so the better fit depends on which thesis you are expressing.

Is CB or ZURVY the better stock?

+

Neither is universally better. CB is the larger incumbent; ZURVY is the smaller challenger and looks pricier on forward earnings. Walnut is informational, not investment advice. Compare what each does, the tie-breaker metrics above, and the risks, then decide which fits your thesis and what you already own.

Which is cheaper, CB or ZURVY?

+

On forward P/E (as of November 2026), CB trades at 12.81x and ZURVY at 14.50x, so CB is the cheaper of the two on next year's expected earnings. A lower multiple is not automatically the better buy: a richer valuation can be justified by faster growth, and a lower one can reflect real risk. Weigh the multiple against how fast each business is compounding.

Should you own both CB and ZURVY?

+

Because they share themes, owning both concentrates you in that theme. That can be intentional (a focused bet) or accidental (less diversification than it looks). Walnut can show your combined exposure across both, and whether adding either over-concentrates you, before you buy.

What are the risks of CB vs ZURVY?

+

CB: As a P&C insurer, Chubb is exposed to large catastrophe losses from hurricanes, wildfires, earthquakes, and other severe events, which can compress margins in a bad year. Reserve adequacy is an ongoing risk, since claims can develop worse than initially estimated, especially in long-tail casualty lines. A large investment portfolio means results are sensitive to interest rates, credit spreads, and equity markets. Competitive pricing cycles (soft markets) can pressure premium growth and underwriting profitability, and consensus already expects EPS growth of only about 1% in 2027. Because it operates globally, Chubb also carries foreign-exchange and geopolitical exposure across many jurisdictions. With the stock near a 52-week high of about $384 after a 22% gain in 2026, the shares sit slightly above the average analyst target of about $374, and some brokers remain cautious (BMO's target is $345). ZURVY: Catastrophe losses are the most visible risk. Zurich's catastrophe loss ratio rose to 3.2% in the first nine months of 2026 from 1.4% a year earlier after third-quarter storms in Switzerland, Germany and Italy, and a severe US hurricane or European flood season can take a large bite out of a year's P&C profit. The commercial pricing cycle is turning: rates fell about 1% in the nine months, and a longer soft market would squeeze margins in the lines where Zurich and Beazley are biggest. Beazley brings integration risk at a large price, plus exposure to cyber and Lloyd's specialty lines that can produce volatile losses; the deal also added about US$2.9 billion of new debt and roughly 7.1 million new shares. US casualty reserves are an industry-wide concern, since lawsuit costs have pushed older claims above their reserves at several insurers. Farmers depends on the health of the Farmers Exchanges, which Zurich manages but does not own. Mario Greco has run Zurich since 2016, so succession is a live question. For US holders, the franc-dollar rate moves the ADR independently of the business, and the 35% Swiss withholding tax on dividends needs paperwork to reclaim. Sector sentiment is a further swing factor: in November 2026 Barclays turned bearish on European insurers as a group, saying their rally had outpaced earnings growth, and the three analysts Yahoo Finance tracks on the ADR have a hold consensus.

Related comparisons

Browse all stock comparisons.

Walnut is informational, not investment advice. This page is descriptive and not a recommendation to buy or sell CB or ZURVY; figures are approximate and dated (as of November 2026). Verify current data before investing.